Santhera Pharmaceuticals Holding AG

Swiss Stock Exchange:SANN.SW

Location

Market Cap

USD 201.60 M

Share Price

USD 15.67

Avg Daily Volume

35,045

Change (1 day)

1.82%

Change (1 year)

70.13%

Change (YTD)

2.53%

Santhera Pharmaceuticals Holding AG Operating Income Margin for the year ending December 31, 2024: -85.34%

Santhera Pharmaceuticals Holding AG Operating Income Margin is -85.34% for the year ending December 31, 2024, a -228.20% change year over year. Operating Income Ratio is the proportion of a company's operating income to its net sales, measuring the efficiency of its core business operations in generating profits.
  • Santhera Pharmaceuticals Holding AG Operating Income Margin for the year ending December 31, 2023 was 66.57%, a -109.57% change year over year.
  • Santhera Pharmaceuticals Holding AG Operating Income Margin for the year ending December 31, 2022 was -695.52%.
  • Santhera Pharmaceuticals Holding AG Operating Income Margin for the year ending December 31, 2020 was -353.65%, a 2,452.85% change year over year.
Key Data
Date Operating Income Margin Gross Profit Margin EBIT Margin EBITDA Margin